Michael J. Detke - Mar 3, 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Chief Medical Officer
Signature
/s/ Caryn Gordon McDowell, Attorney-in-Fact for Michael J. Detke, M.D.
Stock symbol
QNCX
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 04:39 PM
Previous filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Award $0 +140K $0.00 140K Mar 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in equal quarterly installments over two years, with 1/8th of the total number of shares subject to the RSU Award vesting on each quarterly anniversary of the date of grant.